What are the most likely causes of painless hematuria?

Causes of Painless Hematuria

Painless hematuria has a strong association with urologic malignancy, particularly bladder cancer, and warrants urgent evaluation regardless of whether it is gross or microscopic. 1

Key Clinical Distinction

Painless hematuria differs fundamentally from painful hematuria in its diagnostic implications:

• Painless gross hematuria carries a >10% probability of cancer (and >25% in some referral series), making malignancy the primary concern until proven otherwise 1
• Painful hematuria with flank pain is the classic presentation of urinary stone disease, not malignancy 1

Most Likely Causes by Category

Malignant Causes (Primary Concern)

• Bladder cancer - the most common malignancy detected in hematuria evaluations, optimally diagnosed with cystoscopy 1
• Renal cell carcinoma 2
• Urothelial carcinoma of the upper tract 1
• Risk increases significantly in men, persons >35 years, and those with smoking history 2

Benign Urologic Causes

• Benign prostatic hyperplasia (BPH) - one of the three most common causes overall 2
• Urinary tract infection - the most common benign cause, though typically symptomatic 2, 3
• Urinary calculi - common but usually presents with pain 2
• Anatomic abnormalities (congenital or acquired) 1

Glomerular/Renal Causes

• Medical renal disease - suggested by dysmorphic red blood cells, cellular casts, proteinuria, elevated creatinine, or hypertension 2
• These patients require concurrent nephrology and urology referral 2

Critical Clinical Pitfalls

Do Not Dismiss Hematuria in Anticoagulated Patients

• Pursue full evaluation even if the patient is receiving antiplatelet or anticoagulant therapy 1
• 17% of patients bleeding on anticoagulants have an important underlying cause beyond the medication 4

Gross vs. Microscopic Hematuria Risk Stratification

• Any episode of gross hematuria in adults warrants urgent urologic evaluation regardless of whether it is self-limited 1
• Asymptomatic microscopic hematuria (AMH) carries a lower but still significant 0.5-5% cancer risk overall, rising to 7-20% in higher-risk subgroups 1

Essential Evaluation Components

Initial Assessment

• Detailed smoking history (critical risk factor) 1
• Age and sex (risk increases with age >35 years and male sex) 2
• Blood pressure measurement and serum creatinine to assess for medical renal disease 1
• Confirm microscopic hematuria with proper specimen (≥3 RBCs per high-power field) 2

Diagnostic Workup

• Cystoscopy is essential for lower tract evaluation and bladder cancer detection 1, 2
• Multiphasic CT urography is the standard for upper tract imaging 2
• Do NOT obtain urinary cytology or urine-based molecular markers in the initial evaluation 1

When to Refer

• All patients with gross hematuria require urology referral 1
• Microscopically confirmed hematuria without demonstrable benign cause should prompt urology referral for cystoscopy and imaging 1
• Concurrent nephrology referral if glomerular features present 2

Age-Specific Considerations

The diagnostic approach can be tailored by age and hematuria type:

• Patients <30 years with microhematuria only may be evaluated with noncontrast low-dose CT 5
• Patients <40 years presenting only with microhematuria can use low-dose protocols 5
• However, painless gross hematuria at any age requires full evaluation due to high malignancy risk 1